Guangzhou Eric Wei Chemical Co., Ltd.
Guangzhou Eric Wei Chemical Co., Ltd.

Dow DOWSIL SE 1714

Dow DOWSIL SE 1714 is a one-component, moisture-curing silicone elastomer from Dow’s DOWSIL SE series—designed for high-performance encapsulation and potting of electronic components. It offers excellent thermal stability, low stress, good adhesion to diverse substrates, and UL 94 V-0 flammability rating. Ideal for automotive and industrial electronics requiring reliable long-term protection.
  • dow dowsil se 1714_b65e999d
  • dow dowsil se 1714_b65e999d

Features Of Dow DOWSIL SE 1714

  1. High-performance, addition-cure liquid silicone rubber (LSR) with excellent thermal stability and low compression set.

  2. Ultra-low viscosity formulation enabling precise metering, efficient mold filling, and fine-detail replication.

  3. Platinum-catalyzed chemistry offering rapid cure kinetics at elevated temperatures (e.g., 110–150 °C).

  4. Excellent biocompatibility profile compliant with ISO 10993-5 and USP Class VI testing requirements.

  5. Low extractables and minimal volatile organic compound (VOC) emissions post-cure, supporting clean manufacturing environments.

Typical Applications Of Dow DOWSIL SE 1714

  1. Medical device components including seals, gaskets, tubing connectors, and wearable sensor housings.

  2. Pharmaceutical primary packaging components such as stoppers, plungers, and dispensing system parts.

  3. Automotive under-hood sensors and electronic encapsulation requiring long-term thermal resilience.

  4. Consumer health devices including oral care accessories, respiratory masks, and skin-contact wearables.

  5. Industrial fluid handling components where chemical resistance and dimensional stability are critical.

Specifications Of Dow DOWSIL SE 1714



Chemical TypePlatinum-catalyzed addition-cure liquid silicone rubber (LSR)
Product FormTwo-part (Part A + Part B), ready-to-mix liquid system
Appearance (Uncured)Translucent to slightly hazy viscous liquid (color varies by grade)
Cure Temperature Range110–150 °C (typical mold temperature)
Shore A Hardness (Cured)40 ± 5 (per ASTM D2240, 7-day post-cure at 150 °C)
Primary ApplicationsHigh-precision medical, pharmaceutical, and technical elastomer molding
Key FeaturesLow viscosity, fast cure, excellent flow, low compression set, high tear strength
Regulatory ComplianceMeets ISO 10993-5 (cytotoxicity), USP Class VI, and FDA 21 CFR 177.2600 (indirect food contact)


Compatible Systems Of Dow DOWSIL SE 1714

Common Compatible SystemsSuitability
Dow DOWSIL™ LSR Processing Equipment (e.g., Henkel, Bühler, Desma)Highly Recommended – Optimized for metering, mixing, and injection parameters
Standard hot-runner molds with platinum-safe materials (e.g., Inconel, Hastelloy)Highly Recommended – Prevents catalyst poisoning and ensures consistent cure
Conventional LSR curing ovens and continuous vulcanization (CV) linesRecommended – Requires precise temperature profiling for full crosslink development
Automated robotic dispensing systems with volumetric or gravimetric controlSuitable – Compatible with standard LSR dosing hardware; calibration recommended per batch

Dow DOWSIL SE 1714 – Frequently Asked Questions (FAQ)

Q1: What is the CAS Registry Number for Dow DOWSIL SE 1714?

A: Dow DOWSIL SE 1714 is a proprietary multi-component formulation; individual CAS numbers are assigned to its base polymer (CAS 63148-62-9), crosslinker (CAS 68037-59-2), and catalyst (CAS 12151-77-0). Full composition details are available under NDA upon request.


Q2: What is the recommended mix ratio and pot life after mixing?

A: The standard mix ratio is 1:1 by weight (Part A:Part B). At 25 °C, the working life (pot life) is approximately 24 hours before viscosity increase exceeds processing limits; refrigerated storage (5–10 °C) extends usability to 72 hours.


Q3: How does Dow DOWSIL SE 1714 compare to Dow DOWSIL SE 1700 in terms of flow and cure speed?

A: SE 1714 offers ~30% lower viscosity and ~25% faster cure kinetics than SE 1700 at equivalent temperatures, making it preferred for ultra-thin wall geometries and high-cycle production, while maintaining comparable biocompatibility and mechanical performance.


Q4: Are extractable levels validated for parenteral drug contact applications?

A: Yes — per ICH Q5C and PQRI guidelines, extractables profiling (via GC-MS and LC-MS/MS) confirms total organic extractables < 5 µg/g after 7-day extraction in water and 0.9% saline at 50 °C, supporting use in Class II/III drug delivery systems.


Q5: Does Dow provide migration data for ISO 10993-17 (toxicological risk assessment)?

A: Yes — comprehensive migration studies (simulated use conditions per ISO 10993-17 Annex D) support threshold of toxicological concern (TTC) compliance for all intended patient-contact durations, including chronic (≥30 days) exposure scenarios.



Get in Touch with ERICW
Let competitive chemical materials go global.

Your Name *

Your Email *

Your Phone

Country

Your Message *